Overcoming barriers to long-term graft survival

D O I：

10.1053/j.ajkd.2005.12.044

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Although short-term kidney graft survival has improved in recent years, the focus has shifted to the challenge of improving long-term graft survival. Acute rejection, chronic allograft nephropathy, and cardiovascular disease are associated with graft loss and patient death. Reducing the potential for such posttransplantation complications may improve long-term graft survival. In addition, gaining a better understanding of the role that various immunosuppressive therapies have in decreasing the risk for graft injury will help clinicians make better-informed decisions about appropriate treatment regimens for individual kidney transplant recipients.

引用

页码：S52 / S64

页数：13

共 50 条

[1] Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years [J].

Ahsan, N ;

Johnson, C ;

Gonwa, T ;

Halloran, P ;

Stegall, M ;

Hardy, M ;

Metzger, R ;

Shield, C ;

Rocher, L ;

Scandling, J ;

Sorensen, J ;

Mulloy, L ;

Light, J ;

Corwin, C ;

Danovitch, G ;

Wachs, M ;

VanVeldhuisen, P ;

Salm, K ;

Tolzman, D ;

Fitzsimmons, WE .

TRANSPLANTATION, 2001, 72 (02) :245-250

[2] Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study [J].

Boots, JMM ;

Christiaans, MHL ;

van Duijnhoven, EM ;

van Suylen, RJ ;

van Hooff, JP .

TRANSPLANTATION, 2002, 74 (12) :1703-1709

[3] Development and validation of an immunosuppressant therapy adherence barrier instrument [J].

Chisholm, MA ;

Lance, CE ;

Williamson, GM ;

Mulloy, LL .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (01) :181-188

[4] Randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (Neoral)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year [J].

Cianci, G ;

Burke, GW ;

Gaynor, JJ ;

Mattiazzi, A ;

Roth, D ;

Kupin, W ;

Nicolas, M ;

Ruiz, P ;

Rosen, A ;

Miller, J .

TRANSPLANTATION, 2004, 77 (02) :252-258

[5] A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (Neoral) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year [J].

Ciancio, G ;

Burke, GW ;

Gaynor, JJ ;

Mattiazzi, A ;

Roth, D ;

Kupin, W ;

Nicolas, M ;

Ruiz, P ;

Rosen, A ;

Miller, J .

TRANSPLANTATION, 2004, 77 (02) :244-251

[6] Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients [J].

Ciancio, G ;

Burke, GW ;

Suzart, K ;

Roth, D ;

Kupin, W ;

Rosen, A ;

Olson, L ;

Esquenazi, V ;

Miller, J .

TRANSPLANTATION, 2002, 73 (07) :1100-1106

[7] Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients [J].

Cosio, FG ;

Pelletier, RP ;

Pesavento, TE ;

Henry, ML ;

Ferguson, RM ;

Mitchell, L ;

Lemeshow, S .

KIDNEY INTERNATIONAL, 2001, 59 (03) :1158-1164

[8]

*EUR MYC MOF COOR, 2005, LANCET, V345, P1321

[9] Proteinuria:: a new marker of long-term graft and patient survival in kidney transplantation [J].

Fernández-Fresnedo, G ;

Plaza, JJ ;

Sánchez-Plumed, J ;

Sanz-Guajardo, A ;

Palomar-Fontanet, R ;

Arias, M .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 :47-51

[10] A decade of experience with renal transplantation in African-Americans [J].

Foster, CE ;

Philosophe, B ;

Schweitzer, EJ ;

Colonna, JO ;

Farney, AC ;

Jarrell, B ;

Anderson, L ;

Bartlett, ST .

ANNALS OF SURGERY, 2002, 236 (06) :794-804

← 1 2 3 4 5 →